Cathie Wood’s ARK ETF focuses on Roblox and CoreWeave stock buys

Published 16/08/2025, 01:02
© Reuters

Cathie Wood’s ARK ETF released its daily trades for Friday, August 15th, 2025, revealing a series of strategic investments and divestments across various sectors. The largest transaction of the day was the purchase of 125,799 shares of Roblox Corp (PRE-REINCORPORATION) (NYSE:RBLX), spread across three ARK funds, with a total dollar value of $15,760,098. This significant buy reflects a growing trend, as ARK has repeatedly increased its position in Roblox over the past week.

Another notable trade was the acquisition of 120,229 shares of CoreWeave Inc (NASDAQ:CRWV) through its ARKW ETF, amounting to $11,963,987. This purchase underscores ARK’s confidence in the tech sector, particularly in companies with innovative cloud and computing solutions.

ARK’s ARKK ETF also added 165,024 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) to its portfolio, valued at $9,706,711. The investment in CRISPR, a leader in gene-editing technology, aligns with ARK’s focus on disruptive innovation within the healthcare industry.

In the realm of biotechnology, ARK continued to show interest by buying 456,045 shares of Intellia Therapeutics Inc (NASDAQ:NTLA) for $4,970,890 and 417,397 shares of Twist Bioscience Corp (NASDAQ:TWST) at a total value of $12,037,729. Both companies are known for their work in genome editing and synthetic biology.

The fund also made a substantial investment in Deere & Co (NYSE:DE), purchasing 5,075 shares with a total dollar value of $2,430,113, reflecting a continued interest from the previous day’s trading activity.

On the sell side, ARK’s ARKW ETF parted with 190,396 shares of Genius Sports Ltd (NYSE:GENI), totaling $2,458,012. This move might indicate a strategic shift or a reallocation of resources within the fund’s portfolio.

Smaller, yet still significant, buys included 87,033 shares of Block Inc (NYSE:XYZ) worth $6,617,989, and 69,562 shares of Ibotta Inc (NASDAQ:IBTA) totaling $1,643,054, which were distributed between the ARKW and ARKF ETFs.

ARK’s consistent investment pattern, particularly in companies like Roblox, CRISPR Therapeutics, and CoreWeave, suggests a bullish outlook on these stocks’ long-term growth potential. Investors and market watchers will likely keep a close eye on these trends as they develop further.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.